Omega 3 fatty acid supplementation after myocardial infarction: a systematic review and meta-analysis.

ABSTRACT:

Background

The purpose of this review is to examine the effect of Omega-3 Fatty acids on mortality, morbidity, and adverse events in patients with acute myocardial infarction (AMI).

Methods

Data Sources: MEDLINE, EMBASE, and the Cochrane Library through May 2018.

Study selection

Randomized Controlled trials (RCT). Certainty of evidence was assessed with the GRADE system.

Interventions

omega 3 fatty acids against placebo or no treatment. Primary and secondary outcomes: All-cause death, cardiovascular death, new AMI, stroke, need for therapeutic angioplasty or By-pass, new diagnosis of cancer and incidence of adverse events.

Results

For the efficacy endpoints we included 10 RCT (24,414 patients). Omega 3 fatty acids probably make little or no difference to

SUBMITTER: Popoff F 

PROVIDER: S-EPMC6549284 | biostudies-literature | 2019 Jun

REPOSITORIES: biostudies-literature